US 10752702
Anti-TIE2 antibodies and uses thereof
granted A61KA61K2039/505A61K39/3955
Quick answer
US patent 10752702 (Anti-TIE2 antibodies and uses thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Aug 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Aug 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K2039/505, A61K39/3955